Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
VAL‐1221 vs alglucosidase alfa Need for respiratory support · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
VAL‐1221 vs alglucosidase alfa Use of a walking aid/wheelchair · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
VAL‐1221 vs alglucosidase alfa QoL · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
VAL‐1221 vs alglucosidase alfa Treatment‐related adverse events · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Cipaglucosidase plus miglustat vs alglucosidase alfa plus placebo Need for respiratory support · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Cipaglucosidase plus miglustat vs alglucosidase alfa plus placebo Use of a walking aid / wheelchair · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Alglucosidase alfa vs placebo Need for respiratory support · 90 people with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Avalglucosidase alfa vs alglucosidase alfa Need for respiratory support · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Avalglucosidase alfa vs alglucosidase alfa Use of a walking aid / wheelchair · adults with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Alglucosidase alfa vs placebo Use of a walking aid/wheelchair · 90 people with LOPD Enzyme replacement therapy for late‐onset Pompe disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Aromatherapy vs placebo or standard care Tiredness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Aromatherapy vs placebo or standard care Exhaustion · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Aromatherapy vs placebo or standard care Asthenia · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Massage vs no intervention Weakness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Massage vs no intervention Tiredness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Massage vs no intervention Exhaustion · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Massage vs no intervention Asthenia · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs control Weakness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Acupressure vs placebo or control Weakness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Acupressure vs placebo or control Energy · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Acupressure vs placebo or control Tiredness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Acupressure vs placebo or control Exhaustion · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Acupressure vs placebo or control Asthenia · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs control Energy · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs control Tiredness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs control Exhaustion · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Exercise vs control Asthenia · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Aromatherapy vs placebo or standard care Weakness · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Aromatherapy vs placebo or standard care Energy · people receiving dialysis Interventions for fatigue in people with kidney failure requiring dialysis (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Adverse effects of treatment · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Incidence of leg ulcer · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Skin pigmentation changes · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Disease severity signs and symptoms score · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Adverse effects of treatment · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Pain · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Incidence of leg ulcer · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Skin pigmentation changes · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Disease severity signs and symptoms score · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Health‐related quality of life · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs control Mental health service usage ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs control Adverse effects of MHFA ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions Individual mental health ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions Mental health service usage ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative mental health literacy interventions Adverse effects of MHFA ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative intervention Individual mental health ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative intervention Mental health service usage ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Mental Health First Aid (MHFA) training vs alternative intervention Adverse effects of MHFA ‐ not measured · improving mental health and wellbeing Mental Health First Aid as a tool for improving mental health and well‐being (2023) · Cochrane | no estimate extracted | NR | No studies |
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria Neonatal mortality (mortality < 28 days of age) from any cause ‐ not reported · preterm infants at risk of respiratory distress syndrome Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress… (2023) · Cochrane | no estimate extracted | NR | No studies |
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria Bronchopulmonary dysplasia or mortality ‐ not reported · preterm infants at risk of respiratory distress syndrome Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress… (2023) · Cochrane | no estimate extracted | NR | No studies |
Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria Neurodevelopmental outcome at approximately two years' corrected age ‐ not reported · preterm infants at risk of respiratory distress syndrome Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress… (2023) · Cochrane | no estimate extracted | NR | No studies |